tiprankstipranks
Advertisement
Advertisement

BRRGF Stock Latest News

Company AnnouncementsOncoinvent Hits 50% Enrollment in Phase 2 Radspherin Trial for Ovarian Cancer
2M ago
PremiumCompany Announcements
Oncoinvent Aligns Board Incentives with Equity Grants as Radspherin Advances
3M ago
PremiumCompany Announcements
Oncoinvent Clears AGM Agenda as It Pushes Radspherin Toward Post-Surgical Cancer Market
3M ago
PremiumCompany Announcements
Oncoinvent Finalizes Major Share Capital Reduction Amid Progress on Cancer Therapy Radspherin
3M ago
PremiumCompany Announcements
Oncoinvent Advances Radspherin Program With New Patent, Phase 2 Recruitment and CFO Hire
3M ago
PremiumCompany AnnouncementsOncoinvent Sets Virtual AGM as Radspherin Development Advances
3M ago
Premium
Company Announcements
Oncoinvent Sets April Webcast as Radspherin Program Gains Momentum
4M ago
Premium
Company Announcements
Oncoinvent Publishes 2025 Annual Report as Radspherin Program Advances
4M ago
Oncoinvent Secures Key Chinese Patent for Lead Radiopharmaceutical Radspherin
PremiumCompany Announcements
Oncoinvent Secures Key Chinese Patent for Lead Radiopharmaceutical Radspherin
5M ago
Oncoinvent Grants CEO New Share Options as It Advances Radiopharmaceutical Pipeline
PremiumCompany Announcements
Oncoinvent Grants CEO New Share Options as It Advances Radiopharmaceutical Pipeline
5M ago
Oncoinvent Posts Strong 2H 2025 as Radspherin Data and Oslo Uplisting Bolster Growth Plans
PremiumCompany Announcements
Oncoinvent Posts Strong 2H 2025 as Radspherin Data and Oslo Uplisting Bolster Growth Plans
5M ago
Oncoinvent Registers Share Capital Increase Ahead of Reverse Share Split
PremiumCompany Announcements
Oncoinvent Registers Share Capital Increase Ahead of Reverse Share Split
7M ago
Oncoinvent Launches 100-for-1 Reverse Share Split and New ISIN on Oslo Bourse
PremiumCompany AnnouncementsOncoinvent Launches 100-for-1 Reverse Share Split and New ISIN on Oslo Bourse
7M ago
Oncoinvent Grants New CEO Multiyear Share Option Package Tied to Long-Term Growth
Premium
Company Announcements
Oncoinvent Grants New CEO Multiyear Share Option Package Tied to Long-Term Growth
7M ago
Oncoinvent Reshapes Capital Structure After Extraordinary General Meeting
Premium
Company Announcements
Oncoinvent Reshapes Capital Structure After Extraordinary General Meeting
7M ago
Oncoinvent Revamps Option Scheme and Issues New Grants After BerGenBio Merger
PremiumCompany Announcements
Oncoinvent Revamps Option Scheme and Issues New Grants After BerGenBio Merger
8M ago
Oncoinvent Calls Extraordinary General Meeting to Reshape Capital Structure
PremiumCompany Announcements
Oncoinvent Calls Extraordinary General Meeting to Reshape Capital Structure
8M ago
Oncoinvent ASA Completes Rights Issue and Share Capital Adjustment
PremiumCompany Announcements
Oncoinvent ASA Completes Rights Issue and Share Capital Adjustment
8M ago
Oncoinvent’s Radspherin® Shows Promise in Ovarian Cancer Treatment
PremiumCompany Announcements
Oncoinvent’s Radspherin® Shows Promise in Ovarian Cancer Treatment
8M ago
Oncoinvent ASA Announces Rights Issue and Underwriting Commission
PremiumCompany AnnouncementsOncoinvent ASA Announces Rights Issue and Underwriting Commission
8M ago
Oncoinvent ASA Completes Major Rights Issue
Premium
Company Announcements
Oncoinvent ASA Completes Major Rights Issue
8M ago
Oncoinvent ASA Completes NOK 130 Million Rights Issue to Bolster Cancer Therapy Development
Premium
Company Announcements
Oncoinvent ASA Completes NOK 130 Million Rights Issue to Bolster Cancer Therapy Development
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >